PE / VC
1996
$2 000 M
Charlotte, North Carolina, United States
Investment Ticket
Investment Horizon
Investment Stage
Exit Strategy
Profile
Carousel Capital is a private investment firm that focuses on investing in companies located in the Southeastern United States. The firm has an extensive track record of partnering with management teams to build leading companies with national and global presence within its three targeted growth sectors: business services; consumer products and services; and healthcare services. Carousel's investor base is comprised of institutional investors and, since the firm's inception, a group of more than one hundred current and former corporate Chief Executive Officers. These executives assist the firm in sourcing opportunities, as well as providing sector insight and strategic support.
IMPORTANT NOTICE: Unauthorized individuals on WhatsApp (and other social media platforms) are impersonating Carousel Capital team members. We do NOT contact investors on WhatsApp or other social media, and we do NOT provide investment advice through these platforms. If you are contacted by any impersonator or are a victim of online fraud, please file a report with IC3 (ic3.gov) and provide details of the fraudulent behavior.
Industry
Region of investment
Carousel Capital Management Funds
| Name | Type |
|
|
|
Size | AUM | Launch date |
|---|---|---|---|---|---|---|---|
|
Carousel Capital Fund VI
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Services (B2C)
Financial Services
Healthcare Services
IT Services
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$700 M
|
November 2020
|
|
Carousel Capital Partners IV, L.P.
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Healthcare Services
Logistics
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$265 M
|
January 2013
|
|
Carousel Capital Partners V, L.P.
|
Private Equity (PE)
|
Business Services (B2B)
Consumer Products
Consumer Services (B2C)
Healthcare Services
SaaS
Software
Logistics
|
Series B
Late Stage (Series C+)
|
North America
|
$5-10 m
|
$400 M
|
January 2017
|